Cancer risk in HIV patients with incomplete viral suppression after initiation of antiretroviral therapy.
Jennifer S LeeStephen R ColeChad J AchenbachDirk P DittmerDavid B RichardsonWilliam C MillerWm Christopher MathewsKeri N AlthoffRichard D MooreJoseph J Eronnull nullPublished in: PloS one (2018)
Overall risk of first cancer was not associated with incomplete viral suppression; however, cancer remains a significant threat to HIV patients after treatment initiation. As more HIV patients gain access to treatment in the current "treat all" era, occurrences of incomplete viral suppression will be observed more frequently in clinical practice, which supports continued study of the role of low-level HIV RNA on cancer development.
Keyphrases
- antiretroviral therapy
- hiv infected
- hiv positive
- human immunodeficiency virus
- hiv aids
- hiv testing
- papillary thyroid
- end stage renal disease
- hepatitis c virus
- hiv infected patients
- sars cov
- newly diagnosed
- ejection fraction
- men who have sex with men
- clinical practice
- peritoneal dialysis
- squamous cell
- prognostic factors
- south africa
- young adults
- patient reported outcomes
- patient reported